Variety in bone marrow F-18-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?

Hugo J. A. Adams*, John M. H. de Klerk, Rob Fijnheer, Ben G. F. Heggelman, Stefan V. Dubois, Rutger A. J. Nievelstein, Thomas C. Kwee

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

ObjectiveTo directly correlate fluorine-18 fluoro-2-deoxy-d-glucose (F-18-FDG) uptake of the iliac crest, as determined with PET, with both spatially matched histological bone marrow parameters and laboratory markers in Hodgkin lymphoma patients without lymphomatous bone marrow involvement at bone marrow biopsy.Materials and methodsThis retrospective study included 21 patients with newly diagnosed Hodgkin lymphoma who underwent F-18-FDG-PET and who had a lymphoma-negative bone marrow biopsy of the right posterior iliac crest. F-18-FDG-PET maximum standardized uptake value (SUVmax) was measured in the right posterior iliac crest and correlated to histological bone marrow parameters (cellularity, myeloid/erythroid ratio, degree of fibrosis, and reactive T- and B-lymphocytes) and laboratory markers (hemoglobin, C-reactive protein lactate dehydrogenase, and leukocyte and thrombocyte counts) using Pearson's correlation coefficient (R) for Gaussian data or Kendall's tau () for non-Gaussian data.ResultsThere was a significant moderate correlation between F-18-FDG-PET SUVmax and cellularity of the iliac crest (R=0.519, P=0.016). Furthermore, there was a significant strong inverse correlation between F-18-FDG-PET SUVmax of the iliac crest and hemoglobin level (R=-0.661, P=0.001) and there was a significant moderate correlation between F-18-FDG-PET SUVmax of the iliac crest and C-reactive protein level (=0.441, P=0.007). All other correlations, including F-18-FDG-PET SUVmax of the right iliac crest versus reactive T- and B-lymphocytes in the bone marrow, were not significant.ConclusionThe observations suggest increased bone marrow F-18-FDG uptake to be caused by red marrow hyperplasia because of anemia in Hodgkin lymphoma. Increased bone marrow F-18-FDG uptake is unlikely to be caused by inflammatory bone marrow changes.

Original languageEnglish
Pages (from-to)23-29
Number of pages7
JournalNuclear Medicine Communications
Volume37
Issue number1
DOIs
Publication statusPublished - Jan 2016

Keywords

  • biopsy
  • bone marrow
  • F-18-FDG-PET
  • Hodgkin
  • laboratory
  • lymphoma
  • RESPONSE ASSESSMENT
  • FDG-PET/CT
  • METAANALYSIS
  • CONSENSUS
  • BIOPSY

Fingerprint

Dive into the research topics of 'Variety in bone marrow F-18-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?'. Together they form a unique fingerprint.

Cite this